Characterization of the molecular mode of action of the sulfonylurea, glimepiride, at β-cells

Hormone and Metabolic Research

Volumn 28, Issue 9, 1996, Pages 464-468

  Kramer, W ^a   Muller G ^a   Geisen, K ^a  

^a SANOFI   (France)

Author keywords

Diabetes mellitus *(NIDDM); Glibenclamide; Insulin secretion; K(ATP) channels; Non insulin dependent; Sulfonylurea receptor; Sulfonylureas

Indexed keywords

GLIBENCLAMIDE; GLIMEPIRIDE; INSULIN; POTASSIUM CHANNEL; SULFONYLUREA RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; CONFERENCE PAPER; CONTROLLED STUDY; MOLECULAR BIOLOGY; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; RAT;

ANIMALIA;

EID: 0029839173     PISSN: 00185043     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-979838     Document Type: Conference Paper

References (36)

1. Ämmälä, C., A. Moorhouse, F. Gribble, R. Ashfield, P. Proks, P. A. Smith, H. Sakuru, B. Coles, S. J. J. Ashcroft, F. M. Ashcroft: Promiscuous coupling between the sulphonylurea receptor and inwardly rectifying potassium channels. Nature 379: 545-548 (1996)
2. Aguilar-Bryan, L., D. A. Nelson, Q. A. Vu, M. B. Humphrey, A. E. Boyd III: Photoaffinity labeling and partial purification of the β-cell sulfonylurea receptor using a novel, biologically active glyburide analog. J. Biol. Chem. 265: 8218-8224 (1990)
3. Aguilar-Bryan, L., C. G. Nichols, S. W. Wechsler, J. P. Clement IV, G. Gonzalez, H. Herrera-Sosa, K. Nguy, J. Bryan, D. A. Nelson: Cloning of the β-cell high-affinity sulfonylurea receptor: A regulator of insulin secretion. Science 268: 423-426 (1995)
4. Ashcroft, S. J. H., F. M. Ashcroft: Properties and functions of ATP-sensitive K-channels. Cell. Signalling 2: 197-214 (1990)
5. Ashcroft, S. J. H., F. M. Ashcroft: The sulfonylurea receptor. Biochim. Biophys. Acta 1175: 45-59 (1993)
6. Boyd III, A. E.: Sulfonylurea receptors, ion channels, and fruit flies. Diabetes 37: 847-850 (1988)
7. Boyd III, A. E.: The role of ion channels in insulin secretion. J. Cell Biochem. 48: 234-241 (1992)
8. Draeger, E.: Clinical profile of glimepiride. Diabetes Res. Clin. Pract. 28: S139-S146
9. Flatt, P. R., O. Shibier, J. Szecowka, P. O. Berggren: New perspectives on the actions of sulphonylureas and hyperglycaemic sulphonamides on the pancreatic β-cell. Diabete Metab. 20: 157-162 (1994)
10. Gaines, K. L., S. Hamilton, A. E. Boyd III: Characterization of the sulfonylurea receptor on beta cell membranes. J. Biol. Chem. 263: 2589-2592 (1988)
11. Geisen, K.: Special pharmacology of the new sulfonylurea glimepiride. Drug. Res. 38: 1120-1130 (1988)
12. 3H]glibenclamide binding to sulfonylurea receptors by oral antidiabetics. Drug Res. 35: 707-712 (1985)
13. Inagaki, N., T. Gonoi, J. P. Clement IV, N. Namba, J. Inazawa, G. Gonzalez, L. Aguilar-Bryan, S. Seino, J. Bryan: Reconstitution of 1KATP: An inward rectifier subunit plus the sulfonylurea receptor. Science 270: 1166-1170 (1995)
14. Kaubisch, N., R. Hammer, C. Wollheim, A. E. Renold, R. E. Offord: Specific receptors for sulfonylureas in brain and in a β-cell tumor of the rat. Biochem. Pharmacol. 31: 1171-1174 (1982)
15. 3H]glimepiride. Biochim. Biophys. Acta 1191: 278-290 (1994)
16. +-channels. Diabetes Res. Clin. Pract. 28: S67-S80 (1995)
17. 3H]glibenclamide. FEBS Lett. 229: 355-359 (1988)
18. Lebovitz, H. E.: Oral hypoglycemic agents. In: Ellenberg and Rifkin's diabetes mellitus. Theory and practice. H. Rifkin, D. Porte (eds), Elsevier, New York (1990), pp. 554-574
19. Müller, G., A. Korndörfer, U. Kornak, W. J. Malaisse: Porin proteins in mitochondria from rat pancreatic islet cells and white adipocytes: Identification and regulation of hexokinase binding by the sulfonylurea glimepiride. Arch. Biochem. Biophys. 308: 8-23 (1994)
20. Müller, G., Y. Satoh, K. Geisen: Extrapancreatic effects of sulfonylureas - a comparison between glimepiride and conventional sulfonylureas. Diabetes Res. Clin. Pract. 28: S115-S137 (1995)
21. Müller, G., K. Geisen: Characterization of the molecular mode of action of the sulfonylurea, glimepiride, at adipocytes. Horm. Metab. Res. 28: 469-487 (1996)
22. Ozanne, S. E., P. C. Guest, J. C. Hutton, C. N. Hales: Intracellular localization and molecular heterogeneity of the sulphonylurea receptor in insulin-secreting cells. Diabetologia 38: 277-282 (1995)
23. Panten, U., J. Burgfeld, F. Goerke, M. Rennicke, M. Schwanstecher, M. Wallash, A. Zünkler, S. Lenzen: Control of insulin secretion by sulfonylureas, meglitinide and diazoxide in relation to their binding to the sulfonylurea receptor in pancreatic islets. Biochem. Pharmacol. 38: 1217-1229 (1989)
24. Panten, U., M. Schwanstecher, C. Schwanstecher: Mode of action of sulfonylureas. In: Kuhlmann, J., W. Puls (eds): Oral antidiabetics. Handbook of experimental pharmacology, Vol. 119: 129-159 (1995), Springer, Berlin
25. Panten, U., M. Schwanstecher, C. Schwanstecher: Sulfonylurea receptors and mechanism of sulfonylurea action. Exp. Clin. Endocrinol. 104: 1-9 (1996)
26. +-channel. J. Biol. Chem. 262: 15840-15844 (1987)
27. Schwanstecher, M., S. Löser, Ch. Brandt, K. Scheffer, F. Rosenberger, U. Panten: Adenine nucleotide-induced inhibition of binding of sulphonylureas to their receptor in pancreatic islets. Br. J. Pharmacol. 105: 531-534 (1992)
28. Schwanstecher, M., S. Löser, F. Chudziak, U. Panten: Identification of a 38-kDa high affiity sulfonylurea-binding peptide in insulin-secreting cells and cerebral cortex. J. Biol. Chem. 269: 17768-17771 (1994)
29. + channels and stimulation of insulin secretion by the sulfonylurea, glimepiride, in relation to its membrane binding in pancreatic islets. Pharmacology 49: 105-111 (1995)
30. Skeer, J. M., P. Degano, B. Coles, M. Potier, F. M. Ashcroft, S. J. H. Ashcroft: Determination of the molecular mass of the native beta-cell sulfonylurea receptor. FEBS Lett. 338: 98-102 (1994)
31. Sturgess, N. C., M. L. J. Ashcroft, D. L. Cook, C. N. Hales: The sulfonylurea receptor may be an ATP-sensitive potassium channel. Lancet ii: 474-475 (1985)
32. Sugiura, M., Y. Sawada, Y. Yamada, K. Nakamura, T. Iga: Prediction of therapeutic doses of sulfonylureas based on receptor occupancy theory. Xenobiot. Metab. Dispos. 7: 233-241 (1992)
33. Thomas, P. M., G. J. Cote, N. Wohllk, B. Haddad, P. M. Mathew, W. Rabl, L. Aguilar-Bryan, R. F. Gagel, J. Bryan: Mutations in the sulfonylurea receptor gene in familial persistent hyperinsulinemic hypoglycemia of infancy. Science 268: 426-429 (1995)
34. Tsumura, K.: Clinical evaluation of glimepiride (HOE490) in NIDDM, including a double blind comparative study versus gliclazide. Diabetes Res. Clin. Pract. 28: S147-149 (1995)
35. Uihlein, M., N. Sistovaris: High-performance liquid column and thin-layer chromatographic determination of human serum glibenclamide at therapeutic levels. J. Chromatogr. 227: 93-101 (1982)
36. Verspohl, E. J., H. P. T. Ammon, M. Mark: Evidence for more than one binding site for sulfonylureas in insulin-secreting cells. J. Pharm. Pharmacol. 42: 230-235 (1990)